Hyperthermia Aaron McGuffin, M.D..

Slides:



Advertisements
Similar presentations
© 2011 National Safety Council 15-1 ENVIRONMENTAL EMERGENCIES LESSON 15.
Advertisements

Malignant Hyperthermia Catherine Maw 24/10/2012. OUTLINE Define and discuss aetiology of thermal disorders Relevance to ICU Clinical Presentation of MH.
The maintenance of a particular temperature in a living body.
Exercise Thermoregulation, Fluid Balance, and Rehydration Chapter 10 Part 1.
Jeff Holmes M.D. Heat Emergencies. Mechanism of Heat Transfer 1.Convection 2.Radiation 3.Conduction 4.Evaporation **Physiologically, humans are tropical.
Outcomes Research™ Medical Research to Guide Clinical Decisions ©
O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©
Chapter 10.  Transfer of Body Heat ◦ Conduction ◦ Convection ◦ Radiation ◦ Evaporation  Humidity and Heat Loss.
Chapter 17 Environment and Exercise. Heat and Human Physiology Only 15 to 40% of energy is converted into useful work. 60 to 85% of energy is wasted as.
Temperature Regulation. Importance of Temperature Regulation core temps above 41 C result in protein destruction core temps above 45 C can result in death.
Heat and Cold Emergencies
Heat Illness LA Wilson MD, FACEP. Heat Illness- Topics  Epidemiology  Pathophysiology: heat transfer, response to heat stress, path to heat illnesses.
Heat Emergencies Prepared by: Steven Jones, NREMT-P.
Sunrise over Gulf of Mexico
© 2011 National Safety Council COLD AND HEAT EMERGENCIES LESSON
Iron Toxicity. Overview Principle of the disease Clinical features Diagnosis management.
Hypothermia Hyperthermia Dr. Stella Yiu Staff Emergency Physician S Yiu, 2012.
Air temperature Relative Humidity Radiant heat Conductive heat Air movement Workload intensity & duration Personal protective equipment.
Chapter 11 Exercise in Hot and Cold Environments: Thermoregulation.
Sympathomimetic Hyperpyrexia Bob Hoffman, MD. Reported temp 108 o F = 42.2 o C.
Exercise and Thermal Stress
Malignant Hyperthermia
By Asmaa M. Idres.  Pharmacogenic disorder, inherited clinical myopathic syndrome affecting the skeletal muscles causing acute hypermetabolic state Mode.
Critical Care Nursing A Holistic Approach Part 3
Cardiovascular Exercise in the Heat
Malignant hyperthermia
Unit 4: Medical Technologies. - any format of machinery that is used to operate or perform medical procedures.
Too Hot Hyperthermia David Johnson. Causes Endogenous/exogenous Excessive heat production/diminished dissipation Exertional Environmental MH, NMS, thyrotoxicosis,
Heat Loss How heat is lost from the body Evaporation (25%) Radiation (60%) Heat waves Convection to air (12%) Conduction to object (3%) Convection to air.
Hyperthermia Standing Order. HYPERTHERMIA (Heat Illness) State of unusually high core body temp Predisposing Factors: 1. Age of the patient: less tolerable.
Acetaminophen Toxicity. Overview Principle pf the disease Clinical features Diagnosis Management.
Morbidity and Mortality report MICU Bliss 11I Veena Panduranga Juliana Alvarez-Argote.
Without reference, identify principles about Hypothermia Systems with at least 70 percent accuracy.
Neuroleptic Malignant Syndrome (NMS) Sue Henderson.
SPORTS MEDICINE THE EXHAUSTED HORSE SYNDROME
HOT WEATHER FLYING HEALTH HAZARDS OF HEAT AND HUMIDITY Dr. Jim Giordano, AGI, IGI Aviation Safety Counselor
Malignant Hyperthermia (MH)
Malignant Hyperthermia By Aaron Denson 1/30/13. Why do Anesthesiologist Care?  This rare but life-threatening condition is usually triggered by exposure.
Thermoregulation. Homeostasis – Is the stable, constant temperature for the human body to most effectively function. This is around 37 degrees Celsius.
Hyperthermia Revisited James Knochel, MD Clinical Grand Rounds: September 14, 2005.
Malignant Hyperthermia. What is it?What is it? –Malignant hyperthermia (MH) was the name given to a type of severe reaction under general anesthesia that.
Environmental Concerns. Hyperthermia Heat Stress 1. The body will function normally as long as body temperature is maintained in a normal range. 2. Maintaining.
Body Temperature RegulationBody Temperature Regulation Chapter 6 Sections 4Chapter 6 Sections 4.
Presented by Joshua Ward.  Rare, life-threatening condition triggered by drugs used for general anesthesia  Causes uncontrolled increase in skeletal.
Chapter 1 Vital Signs Copyright © The McGraw-Hill Companies, Inc.
Chapter 24 Vital Signs.
Effects of Environment on Performance - Thermoregulation Sharni Symes & Stacie Cole.
Malignant hyperthermia Dr S Spijkerman. Pathogenesis.
ENVIRONMENTAL EMERGENCIES. HEAT CRAMPS Result from depletion of fluid and electrolytes in exerted muscles Symptoms: pain in exerted muscles and thirst.
Local Application of heat and cold to the body can be therapeutic, but before using these therapies, the nurse must understand normal body responses to.
Environmental emergencies Aaron J. Katz, AEMT-P, CIC
Newborn infant By : Dr.Sanjeev. Thermal protection in newborn Due to reduced subcutaneous and brown fat Brown fat : - Site : adrenal glands, kidneys,
HYPERTHERMIA THERMOREGULATION. HYPERTHERMIA Learning Outcomes Describe the pathophysiology, etiology, clinical manifestations, and direct and indirect.
Malignant hyperthermia Some genetically predisposed patients experience a severe reaction, designated malignant hyperthermia, on exposure to certain anesthetics.
Acetaminophen Intoxication Ali Labaf M.D. Assistant professor Department of Emergency Medicine Tehran University of Medical Science.
THERMOREGULATION.
FEVER Friend or Foe? Or Both?
Malignant Hyperthermia
Malignant Hyperthermia
Serotonin syndrome – one minute read
Temperature Regulation
Thermoregulation Mary Roche, RN, MSN, CS
1396/01/14.
麻醉科主任 覃事台
Malignant Hyperthermia
What Everyone Should Know.
Skeletal muscle junction
DROWNING.
Thermoregulation Taylor, ch 25.
Presentation transcript:

Hyperthermia Aaron McGuffin, M.D.

Definition Elevation of core body temperature above the normal diurnal range of 36ºC to 37.5ºC due to failure of thermoregulation Hyperthermia is not synonymous with the more common sign of fever, which is induced by cytokine activation during inflammation, and regulated at the level of the hypothalamus

Hyperthermia The most important causes of severe hyperthermia (greater than 40ºC or 104ºF) caused by failure of thermoregulation are: Heat stroke Neuroleptic malignant syndrome Malignant hyperthermia

Physiology Body temperature is maintained within a narrow range by balancing heat load with heat dissipation. Body's heat load results from both metabolic processes and absorption of heat from the environment As core temperature rises, the preoptic nucleus of the anterior hypothalamus stimulates efferent fibers of the ANS to produce sweating and cutaneous vasodilation.

Physiology Evaporation is the principal mechanism of heat loss in a hot environment, but this becomes ineffective above a relative humidity of 75% Other methods of heat dissipation Radiation- emission of infrared electromagnetic energy Conduction- direct transfer of heat to an adjacent, cooler object Convection-direct transfer of heat to convective air currents These methods cannot efficiently transfer heat when environmental temperature exceeds skin temperature.

Physiology Temperature elevation  ↑ O2 consumption and metabolic rate  hyperpnea and tachycardia Above 42ºC (108ºF), oxidative phosphorylation becomes uncoupled, and a variety of enzymes cease to function. Hepatocytes, vascular endothelium, and neural tissue are most sensitive to these effects, but all organs may be involved. As a result, these patients are at risk of multiorgan system failure.

Heat Stroke Core body temperature > 40.5ºC (105ºF) with associated CNS dysfunction in the setting of a large environmental heat load that cannot be dissipated Complications include: ARDS DIC Renal or hepatic failure Hypoglycemia Rhabdomyolysis Seizures

Classic (nonexertional) heat stroke Affects individuals with underlying chronic medical conditions that either impair thermoregulation or prevent removal from a hot environment. Conditions include: Cardiovascular disease Neurologic or psychiatric disorders Obesity Anhidrosis Extremes of age Anticholinergic agents or diuretics

Exertional heat stroke Occurs in young, otherwise healthy individuals engaged in heavy exercise during periods of high ambient temperature and humidity Findings include cutaneous vasodilation, tachypnea, rales due to noncardiogenic pulmonary edema, excessive bleeding due to DIC, altered mentation or seizures Labs: coagulopathy, ARF, elevated LFTs due to acute hepatic necrosis, respiratory alkalosis, and a leukocytosis as high as 30,000 to 40,000/mm3 One series of 58 patients with heat stroke found an acute mortality rate of 21 percent (Ann Intern Med 1998 Aug 1;129(3):173-81)

Malignant Hyperthermia Rare genetic disorder manifests after tx with anesthetic agents: succinylcholine and halothane Onset is usually in 1 hour of the administration of anesthesia, rarely delayed up to 10 hours ½ of cases are inherited in as AD; Rest are inherited in different patterns. Susceptible patients with AD disease have any one of several distinct mutations in the gene for the SKM ryanodine receptor (RyR1) which is a homotetrameric Ca++ channel in the sarcoplasmic reticulum of SKM In the presence of anesthetic agents, alterations in the hydrophilic, amino-terminal portion of the ryanodine receptor uncontrolled Ca ++ efflux from the SR  tetany,↑ SKM metabolism, and heat production For unclear reasons, overexpression of the wild-type ryanodine receptor does not ablate abnormal myocyte responses to halothane although overexpression of a mutated ryanodine receptor can induce the malignant hyperthermia phenotype in myocytes from normal individuals

Malignant Hyperthermia Early clinical findings in malignant hyperthermia include muscle rigidity (especially masseter stiffness), sinus tachycardia, increased CO2 production, and skin cyanosis with mottling Marked hyperthermia (up to 45ºC [113ºF]) occurs minutes to hours later; core body temperature tends to rise 1ºC every 5 to 60 minutes. Hypotension, complex dysrhythmias, rhabdomyolysis, electrolyte abnormalities, DIC and mixed acidosis accompany the elevated temperature. Rarely, biochemically-proven malignant hyperthermia may present solely with rhabdomyolysis in the absence of hyperthermia

Neuroleptic malignant syndrome Idiosyncratic reaction to antipsychotic agents. IN addition to hyperthermia, NMS is also characterized by "lead pipe" muscle rigidity, altered mental status, choreoathetosis, tremors, and evidence of autonomic dysfunction, such as diaphoresis, labile blood pressure, and dysrhythmias.

DIAGNOSTIC EVALUATION Get a rectal temperature; abnormal VS include sinus tachycardia, tachypnea, widened pulse pressure, hypotension CXR may demonstrate pulmonary edema EKG may reveal dysrhythmias, conduction disturbances, nonspecific ST-T wave changes, or heat-related myocardial ischemia or infarction Labs: CBC CCP, Coagulation Studies, creatine kinase, and check for hyperphosphatemia, myoglobinuria Myoglobinuria should be suspected in a patient who has a brown urine supernatant that is heme-positive, and clear plasma. Toxicologic screening may be indicated if a medication effect is suspected. Head CT and lumbar puncture if CNS etiologies suspected

DIAGNOSTIC EVALUATION Diagnosis confirmed by in vitro muscle contracture test following recovery from the acute hyperthermic episode. Abnormal augmentation of in vitro muscle contraction following treatment with halothane or caffeine is diagnostic of the disorder However, this test is expensive, not widely available, and frequently not covered by insurance. Genetic testing for the more than 40 known mutations of the SKM ryanodine receptor (RyR1) can be used in conjunction with the in vitro muscle contracture test to evaluate individual susceptibility in patients from families with a history of malignant hyperthermia

Management Ensure ABCs, initiate rapid cooling, tx complications

Management

Management CVP monitoring is useful for assessing volume status and determining the need for fluid resuscitation Alpha-adrenergic agonists should be avoided, since the resultant vasoconstriction decreases heat dissipation. Continuous core temperature monitoring with a rectal or esophageal probe is mandatory, and cooling measures should be stopped once a temperature of 39.5ºC (103ºF) has been achieved in order to reduce the risk of iatrogenic hypothermia In the case of NMS or malignant hyperthermia, the presumed causative agent must be discontinued immediately

Management Cooling measures Naked patient is sprayed with a mist of lukewarm water while air is circulated with large fans. Shivering may be suppressed with intravenous benzodiazepines such as diazepam (5 mg IV) or lorazepam (1-2 mg IV) or, if NMS is not suspected, with chlorpromazine (25 to 50 mg IV). Immersing the patient in ice water is the most effective method of rapid cooling but complicates monitoring and access Applying ice packs to the axillae, neck, and groin is effective, but is poorly tolerated in the awake patient

Management Cooling Measures Cold peritoneal lavage results in rapid cooling, but it is an invasive technique that is contraindicated in pregnant patients or those with previous abdominal surgery. Cold oxygen, cold gastric lavage, cooling blankets, and cold intravenous fluids may be helpful adjuncts. There is no role for antipyretic agents such as acetaminophen or ASA in the management of heat stroke, since the underlying mechanism does not involve a change in the hypothalamic set-point Alcohol sponge baths should be avoided because large amounts of the drug may be absorbed through dilated cutaneous vessels and produce toxicity

Management: Malignant hyperthermia Dantrolene administration is the mainstay of treatment of malignant hyperthermia, and should be initiated as soon as the diagnosis is suspected. Since the introduction of dantrolene, the mortality of the fulminant syndrome has fallen from close to 70 percent to less than 10 percent. Dantrolene is a nonspecific SKM relaxant that acts by blocking the release of calcium from the SR  decreases the myoplasmic concentration of free calcium and diminishes the myocyte hypermetabolism that causes clinical symptoms. Most effective when given early in the illness (ie, before hyperthermia occurs), when maximal calcium can be retained within the SR A 2 mg/kg IV bolus is given and should be repeated every 5 minutes until symptoms abate up to a maximum dose of 10 mg/kg. This may be repeated every 10 to 15 hours. After an initial response, the drug should be continued orally at a dose of 4 to 8 mg/kg per day, in four divided doses, for three days.